Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline

Company Overview - Bio-Rad Laboratories (BIO) is anticipated to report a year-over-year decline in earnings due to lower revenues for the quarter ended December 2024 [1] - The earnings report is scheduled for release on February 13, 2025, and could influence the stock price depending on whether the results meet or exceed expectations [2] Earnings Estimates - The Zacks Consensus Estimate predicts quarterly earnings of $2.92 per share, reflecting a year-over-year decrease of 5.8$674.71 million, which is a 1% decline from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised down by 0.22% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][10] - Bio-Rad's Earnings ESP is currently at -2.06%, suggesting a lower Most Accurate Estimate compared to the Zacks Consensus Estimate [11] Earnings Surprise History - In the last reported quarter, Bio-Rad exceeded expectations by delivering earnings of $2.01 per share against an expected$1.28, resulting in a surprise of +57.03% [12] - Over the past four quarters, the company has consistently beaten consensus EPS estimates [13] Market Sentiment - Despite the historical ability to beat estimates, the current combination of a negative Earnings ESP and a Zacks Rank of 2 (Buy) complicates predictions for the upcoming earnings report [11][16] - The company does not appear to be a compelling candidate for an earnings beat based on current indicators, but other factors should also be considered by investors [16]